The CD52 antigen was extracted from human spleens with organic solvents and purified by immunoaffinity and reverse-phase chromatography. The latter step resolved two CD52 species, called CD52-I and CD52-II. Both species were found to contain similar N-linked oligosaccharides and glycosylphosphatidylinositol (GPI) anchor glycans. The N-linked oligosaccharides were characterized by methylation linkage analysis and, following exhaustive neuraminidase and endo--galactosidase digestion, by the reagent array analysis method. The results showed that the single CD52 N-glycosylation site is occupied by large sialylated, polylactosamine-containing, core-fucosylated tetraantennary oligosaccharides. The locations of the phosphoryl substituents on the GPI anchor glycan were determined using a new and sensitive method based upon partial acid hydrolysis of the GPI glycan.

The difference between CD52-I and CD52-II was in the phosphatidylinositol (PI) moieties of the GPI anchors. The phosphatidylinositol-specific phospholipase C-sensitive CD52-I contained exclusively distearoyl-PI, while the PI-phospholipase C-resistant CD52-II contained predominantly a palmitoylated stearoyl-arachidonoyl-PI, as judged by electrospray ionization mass spectrometry. Tandem mass spectrometric studies indicated that the palmitoyl residue of the CD52-II anchor is attached to the 2-position of the myo-inositol ring. Both the CD52-I and CD52-II PI structures are unusual for GPI anchors and the possible significance of this is discussed.

The alkali-lability of the CD52 epitope recognized by the Campath-1H monoclonal antibody was studied. The data suggest that the alkali-labile hydroxyester-linked fatty acids of the GPI anchor are necessary for antibody binding.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				P. Hillmen, A. B. Skotnicki, T. Robak, B. Jaksic, A. Dmoszynska, J. Wu, C. Sirard, and J. Mayer Alemtuzumab Compared With Chlorambucil As First-Line Therapy for Chronic Lymphocytic Leukemia J. Clin. Oncol., December 10, 2007; 25(35): 5616 - 5623. [Abstract] [Full Text] [PDF]

				J. M. Flynn and J. C. Byrd Have We Forgotten the Purpose of Phase III Studies? J. Clin. Oncol., December 10, 2007; 25(35): 5553 - 5555. [Full Text] [PDF]

				S. Parry, N.-K. Wong, R. L Easton, M. Panico, S. M Haslam, H. R Morris, P. Anderson, K. L Klotz, J. C Herr, A. B Diekman, et al. The sperm agglutination antigen-1 (SAGA-1) glycoforms of CD52 are O-glycosylated Glycobiology, October 1, 2007; 17(10): 1120 - 1126. [Abstract] [Full Text] [PDF]

				T. Houjou, J. Hayakawa, R. Watanabe, Y. Tashima, Y. Maeda, T. Kinoshita, and R. Taguchi Changes in molecular species profiles of glycosylphosphatidylinositol anchor precursors in early stages of biosynthesis J. Lipid Res., July 1, 2007; 48(7): 1599 - 1606. [Abstract] [Full Text] [PDF]

				Y. Maeda, Y. Tashima, T. Houjou, M. Fujita, T. Yoko-o, Y. Jigami, R. Taguchi, and T. Kinoshita Fatty Acid Remodeling of GPI-anchored Proteins Is Required for Their Raft Association Mol. Biol. Cell, April 1, 2007; 18(4): 1497 - 1506. [Abstract] [Full Text] [PDF]

				P. L. Zhang, J. R. Pennington, J. W. Prichard, T. M. Blasick, A. M. Brown, and S. Potdar CD52 Antigen May Be a Therapeutic Target for Eosinophilic Rhinosinusitis Ann. Clin. Lab. Sci., January 1, 2007; 37(2): 148 - 151. [Abstract] [Full Text] [PDF]

				M. Montillo, A. Tedeschi, S. Miqueleiz, S. Veronese, R. Cairoli, L. Intropido, F. Ricci, A. Colosimo, B. Scarpati, M. Montagna, et al. Alemtuzumab As Consolidation After a Response to Fludarabine Is Effective in Purging Residual Disease in Patients With Chronic Lymphocytic Leukemia J. Clin. Oncol., May 20, 2006; 24(15): 2337 - 2342. [Abstract] [Full Text] [PDF]

				Y. Tashima, R. Taguchi, C. Murata, H. Ashida, T. Kinoshita, and Y. Maeda PGAP2 Is Essential for Correct Processing and Stable Expression of GPI-anchored Proteins Mol. Biol. Cell, March 1, 2006; 17(3): 1410 - 1420. [Abstract] [Full Text] [PDF]

				J. I. MacRae, A. Acosta-Serrano, N. A. Morrice, A. Mehlert, and M. A. J. Ferguson Structural Characterization of NETNES, a Novel Glycoconjugate in Trypanosoma cruzi Epimastigotes J. Biol. Chem., April 1, 2005; 280(13): 12201 - 12211. [Abstract] [Full Text] [PDF]

				T. S. Lin, I. W. Flinn, R. Modali, T. A. Lehman, J. Webb, S. Waymer, M. E. Moran, M. S. Lucas, S. S. Farag, and J. C. Byrd FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia Blood, January 1, 2005; 105(1): 289 - 291. [Abstract] [Full Text] [PDF]

				B. W. Taron, P. A. Colussi, J. M. Wiedman, P. Orlean, and C. H. Taron Human Smp3p Adds a Fourth Mannose to Yeast and Human Glycosylphosphatidylinositol Precursors in Vivo J. Biol. Chem., August 20, 2004; 279(34): 36083 - 36092. [Abstract] [Full Text] [PDF]

				J. C. Byrd, S. Stilgenbauer, and I. W. Flinn Chronic Lymphocytic Leukemia Hematology, January 1, 2004; 2004(1): 163 - 183. [Abstract] [Full Text] [PDF]

				A.-C. Schlaeppi, T. Malherbe, and P. Butikofer Coordinate Expression of GPEET Procyclin and Its Membrane-associated Kinase in Trypanosoma brucei Procyclic Forms J. Biol. Chem., December 12, 2003; 278(50): 49980 - 49987. [Abstract] [Full Text] [PDF]

				A. Hasegawa, Y. Fu, H. Tsubamoto, Y. Tsuji, H. Sawai, S. Komori, and K. Koyama Epitope analysis for human sperm-immobilizing monoclonal antibodies, MAb H6-3C4, 1G12 and campath-1 Mol. Hum. Reprod., June 1, 2003; 9(6): 337 - 343. [Abstract] [Full Text] [PDF]

				L. M. Thomson, D. J. Lamont, A. Mehlert, J. D. Barry, and M. A. J. Ferguson Partial Structure of Glutamic Acid and Alanine-rich Protein, a Major Surface Glycoprotein of the Insect Stages of Trypanosoma congolense J. Biol. Chem., December 6, 2002; 277(50): 48899 - 48904. [Abstract] [Full Text] [PDF]

				T. C. McCauley, B. E. Kurth, E. J. Norton, K. L. Klotz, V. A. Westbrook, A. J. Rao, J. C. Herr, and A. B. Diekman Analysis of a Human Sperm CD52 Glycoform in Primates: Identification of an Animal Model for Immunocontraceptive Vaccine Development Biol Reprod, June 1, 2002; 66(6): 1681 - 1688. [Abstract] [Full Text] [PDF]

				M. J. Keating, I. Flinn, V. Jain, J.-L. Binet, P. Hillmen, J. Byrd, M. Albitar, L. Brettman, P. Santabarbara, B. Wacker, et al. Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study Blood, May 15, 2002; 99(10): 3554 - 3561. [Abstract] [Full Text] [PDF]

				A. D. De Silva, J.-J. Park, N. Matsuki, A. K. Stanic, R. R. Brutkiewicz, M. E. Medof, and S. Joyce Lipid Protein Interactions: The Assembly of CD1d1 with Cellular Phospholipids Occurs in the Endoplasmic Reticulum J. Immunol., January 15, 2002; 168(2): 723 - 733. [Abstract] [Full Text] [PDF]

				P. BUTIKOFER, T. MALHERBE, M. BOSCHUNG, and I. RODITI GPI-anchored proteins: now you see 'em, now you don't FASEB J, February 1, 2001; 15(2): 545 - 548. [Abstract] [Full Text] [PDF]

				Y. S. Morita, A. Acosta-Serrano, L. U. Buxbaum, and P. T. Englund Glycosyl Phosphatidylinositol Myristoylation in African Trypanosomes. NEW INTERMEDIATES IN THE PATHWAY FOR FATTY ACID REMODELING J. Biol. Chem., May 5, 2000; 275(19): 14147 - 14154. [Abstract] [Full Text] [PDF]

				R. A. Hederer, C. Guntermann, N. Miller, P. Nagy, J. Szollosi, S. Damjanovich, G. Hale, and D. R. Alexander The CD45 tyrosine phosphatase regulates Campath-1H (CD52)-induced TCR-dependent signal transduction in human T cells Int. Immunol., April 1, 2000; 12(4): 505 - 516. [Abstract] [Full Text] [PDF]

				S. Schroter, P. Derr, H. S. Conradt, M. Nimtz, G. Hale, and C. Kirchhoff Male-specific Modification of Human CD52 J. Biol. Chem., October 15, 1999; 274(42): 29862 - 29873. [Abstract] [Full Text] [PDF]

				A. B. DIEKMAN, E. J. NORTON, K. L. KLOTZ, V. A. WESTBROOK, H. SHIBAHARA, S. NAABY-HANSEN, C. J. FLICKINGER, and J. C. HERR N-linked glycan of a sperm CD52 glycoform associated with human infertility FASEB J, August 1, 1999; 13(11): 1303 - 1313. [Abstract] [Full Text]

				A. Benachour, G. Sipos, I. Flury, F. Reggiori, E. Canivenc-Gansel, C. Vionnet, A. Conzelmann, and M. Benghezal Deletion of GPI7, a Yeast Gene Required for Addition of a Side Chain to the Glycosylphosphatidylinositol (GPI) Core Structure, Affects GPI Protein Transport, Remodeling, and Cell Wall Integrity J. Biol. Chem., May 21, 1999; 274(21): 15251 - 15261. [Abstract] [Full Text] [PDF]

				L. K. Gilliland, L. A. Walsh, M. R. Frewin, M. P. Wise, M. Tone, G. Hale, D. Kioussis, and H. Waldmann Elimination of the Immunogenicity of Therapeutic Antibodies J. Immunol., March 15, 1999; 162(6): 3663 - 3671. [Abstract] [Full Text] [PDF]

				M. Ferguson The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research J. Cell Sci., January 9, 1999; 112(17): 2799 - 2809. [Abstract] [PDF]

				R. Focarelli, S. Francavilla, F. Francavilla, C. D. Giovampaola, A. Santucci, and F. Rosati A sialoglycoprotein, gp20, of the human capacitated sperm surface is a homologue of the leukocyte CD52 antigen: analysis of the effect of anti-CD52 monoclonal antibody (CAMPATH-1) on capacitated spermatozoa Mol. Hum. Reprod., January 1, 1999; 5(1): 46 - 51. [Abstract] [Full Text] [PDF]

				P. M. Rudd, B. P. Morgan, M. R. Wormald, D. J. Harvey, C. W. van den Berg, S. J. Davis, M. A.J. Ferguson, and R. A. Dwek The Glycosylation of the Complement Regulatory Protein, Human Erythrocyte CD59 J. Biol. Chem., March 14, 1997; 272(11): 7229 - 7244. [Abstract] [Full Text] [PDF]

				I. A. Brewis, M. A. J. Ferguson, A. Mehlert, A. J. Turner, and N. M. Hooper Structures of the Glycosyl-phosphatidylinositol Anchors of Porcine and Human Renal Membrane Dipeptidase J. Biol. Chem., September 29, 1995; 270(39): 22946 - 22956. [Abstract] [Full Text] [PDF]